Acer Therapeutics Inc (NASDAQ:ACER)

18.91
Delayed Data
As of 11:06am ET
 -0.035 / -0.18%
Today’s Change
5.70
Today|||52-Week Range
22.63
+36.50%
Year-to-Date
No recent news for Acer Therapeutics Inc.

Today’s Trading

Previous close18.94
Today’s open18.70
Day’s range18.70 - 18.96
Volume1,332
Average volume (3 months)30,175
Market cap$145.9M
Data as of 11:06am ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+26.24%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book6.53

Competitors

 Today’s
change
Today’s
% change
EVFMEvofem Biosciences I...-0.17-2.66%
--Achieve Life Science...+0.05+4.20%
MBVXMabVax Therapeutics ...-0.04-2.68%
CPHIChina Pharma Holding...-0.01-2.77%
Data as of 11:08am ET, 04/20/2018

Financials

Next reporting dateMay 11, 2018
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$0.00
Annual profit (last year)-$14.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
Chief Financial Officer
Harry S. Palmin
Corporate headquarters
Newton, Massachusetts

Forecasts